DHA Enterprise-Wide Commercial Solutions Opening (CSO)

The Defense Health Agency (DHA) is seeking commercial solutions to deliver medical readiness to the warfighter at scale, on time, and with precision. The DHA Enterprise-Wide Commercial Solutions Opening (CSO) is a competitive solicitation that will utilize a streamlined, multi-step advisory procedure to minimize barriers to entry for commercial vendors. The CSO will remain open until August 6, 2027, and the Government may post new, extend, or revise Areas of Interest (AoIs) at any time. • The primary purpose of this CSO is to solicit proposals for commercial solutions comprising commercial products, commercial services, and non-developmental items. • The Government will evaluate submissions based on their commercial feasibility, technical merit, technology readiness level, and cost-effectiveness. • The CSO will be administered by the DHACA Defense Healthcare Management Systems Contracting Division (DHMS-CD). • The DHA has three Portfolio Acquisition Executives (PAE) responsible for Medical Digital Solutions, Medical Services, and Medical Products.